Clinical Center News
Summer 2019

First-in-human gene therapy launches with pediatric patient with rare disease

Pediatric patient lays in bed as a nurse situates an IV
In May 2019 pediatric patient JoJo received a first-in-human gene therapy.
Pediatric patient sits on the bed with her care provider, as a tea set, tea cakes and flowers are on display in celebration of her gene therapy
When JoJo, a pediatric patient with a rare disease, first starting coming to the NIH Clinical Center she decided to give each doctor a nickname. Her care provider, Dr. Cynthia Tifft (right), was from then on known as 'Dr. Grandma'. Every year JoJo has returned she and 'Dr. Grandma' have had a traditional tea party to look forward to – typically, no boys allowed. But this year, just before her first-in-human gene therapy, 'Dr. Grandma' had to explain to JoJo that boys would be invited because it was a very special day.
Pediatric patient surrounded by 15 adults who are a part of her care
Ten-year-old JoJo, her family, NIH care providers and extramural collaborators gather in her room just before the first-in-human gene therapy infusion of GLB1, hoping to halt the effects of her neurogenerative disease, GM1 gangliosidosis, and possibly restore speech and movement, among other things, that have already diminished.

In May, a ten-year-old girl named JoJo received a gene therapy for an extremely rare neurogenerative disease called GM1 gangliosidosis.

GM1 progressively destroys nerve cells (neurons) in the brain and spinal cord, leading to muscle and movement weakness, difficulty swallowing and a shortened life expectancy. The first-in-human gene therapy trial was led by Dr. Cynthia Tifft with the National Human Genome Research Institute and partners at the University of Massachusetts and Auburn University. The therapy provides a replacement, or normal, copy of the gene GLB1. The gene is encapsulated in a virus that has shown it targets the central nervous system.

"It's like a viral infection. The viral code dumps the DNA into a cell," Tifft said. "All the guts of the virus (the DNA of the virus) has pretty much been eliminated to make room for the gene you want. The gene we want is sitting in the cell and will begin to make the enzyme that is deficient in the child."

JoJo is one of 35 patients who are a part of an NHGRI natural history study for GM1.

"There was very little known about the disease until about 10 years ago when we started doing a natural history study," said Tifft, principal investigator of the trial. "Based on data that we obtained doing our natural history study in the Clinical Center, the only place we could have ever done it, we basically had enough data to launch a gene therapy trial."

As for most scientific research, Tifft said this has been quite the odyssey. JoJo has been coming here for four years. She used to talk and walk quite well, but now only has the ability to say a few single words and cannot hold herself upright.

When it came time for the 30 minute IV infusion of the gene therapy, a medical advancement a decade in the making, Tifft recalls the moment feeling "almost spiritual."

"It was kind of surreal almost because you think you know what's going to happen and how things are going to work," Tifft said. "While JoJo slept peacefully, 30 of us stood quietly in her dimly lit room listening to the infusion pump and watching her sleep."

While it's still early to tell, at about three weeks post-gene transplant, Tifft said "JoJo stood independently for five minutes. I haven't seen her stand like that for almost two years. That makes me really optimistic."

The care team plans to bring in the second patient mid-August and the third patient mid-November. They will follow each patient for five years, post-gene therapy.

- Molly Freimuth

Nurses working on a pedigree diagram within a patient's medical record
nurse kneeling beside a pediatric patient
people gathered around computers
Patient standing with care providers
The metabolic kitchen staff creating precisely measured ultra-processed and unprocessed meals for study participants
Attendees of the Open Notes session gathered together
Pediatric patient ten-year-old JoJo with Dr. Cynthia Tifft
Branden Bolivar proposes to Marissa Amuso, a patient, May 9 at the NIH Clinical Center
Tom Kaminski with Dr. Sherman Souther
Kayden Reinke, at the age of 2, holding Lammie
Project SEARCH graduates and team
Dr. Marijo Bilusic
Singer-songwriter and pianist Chris Urquiaga
Three women photographed with an award
Man in fatigues talking to care provider
A pediatric patient with her mother and members of the NIH Blood Bank
NIH musical group led by Dr. Collins performing on stage
Dr. Eric Betzig at the podium
Children conducting a science experiment
Trina Davis
Graphic of a cochlear implant
Staff member using a sewing machine
Dr. Saul Rosen
a patient's wristband getting scanned upon checking in or out
Michael Bard, a volunteer medical musician, holds his guitar in a patient room
Nancy Holmfeld
Rare Disease Day logo
People dancing in the atrium
people taking a selfie
Health Information Management Department staff posing for a photo
Young boy holds up a sign that says I love clean hands
FEVS logo
Teresa Bauch showing children cultures of infectious diseases on Take Your Child to Work Day
Staff at the site of a new facility
Woman typing on a Workstation on Wheels computer
Staff view a piece of paper in a kitchen
Men on stage at the awards
Josh and Lisa Danielpour
A redesigned common area in the NIH Clinical Center Edmond J. Safra Family Lodge
Nicholas Rodriquez enjoying the Virtual Reality experience
A young boy voting on gingerbread houses
Retired Navy Capt. Pius A. Aiyelawo speaking at the NIH Veterans Day Celebration Nov. 7
Pediatric patients are given candy by departments at the Clinical Center
a man smiling
Workplace Climate and Harassment Survey. Take the Survey now.
Karen Baker, Dr. Colleen Hadigan and Victoria Anderson stand in a hallway.